The rising role of TRPA1 in asthma

Open Drug Discovery Journal

Volumn 2, Issue SPEC. ISS.2, 2010, Pages 71-80

  Facchinetti, Fabrizio ^a   Patacchini, Riccardo ^a  

^a CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

AITC; AP18; Asthma; Cough; Formalin; HC 030031; Neurogenic inflammation; Respiratory; TRP channel; TRPA1

Indexed keywords

ALDEHYDE; ALLERGEN; ANTIASTHMATIC AGENT; AP 18; BRADYKININ; CAMPHOR; CHLORINE; CINNAMALDEHYDE; CYCLOPENTENONE ISOPROSTANE; CYCLOPENTENONE PROSTAGLANDIN; DIISOCYANATE; HC 030031; ISOCYANIC ACID DERIVATIVE; ISOPROSTANE DERIVATIVE; NERVE GROWTH FACTOR; PROSTAGLANDIN; PROTEINASE ACTIVATED RECEPTOR 2; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RUTHENIUM RED; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; UNCLASSIFIED DRUG;

ALLERGIC AIRWAY INFLAMMATION; ARTICLE; ASTHMA; CHRONIC COUGH; CIGARETTE SMOKING; COUGHING; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; HUMAN; HYPERALGESIA; IC 50; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PHOTOCHEMICAL SMOG; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SENSITIVITY ANALYSIS;

EID: 80053006692     PISSN: None     EISSN: 18773818     Source Type: Journal    
DOI: 10.2174/1877381801002030071     Document Type: Article

References (101)

1. Adcock, I.M.; Caramori, G.; Chung, K.F. New targets for drug development in asthma. Lancet, 2008, 372(9643), 1073-1087.
2. Geppetti, P.; Holzer, P. Neurogenic inflammation. 1996, CRC Press, Boca Raton.
3. García-Añoveros, J.; Nagata, K. TRPA1. Handb. Exp. Pharmacol., 2007, 179, 347-362.
4. Doerner, J.F.; Gisselmann, G.; Hatt, H.; Wetzel, C.H. Transient receptor potential channel A1 is directly gated by calcium ions. J. Biol. Chem., 2007, 282(18), 13180-13189.
5. 2+. Nat. Neurosci., 2007, 10, 277-279.
6. Story, G.M.; Peier, A.M.; Reeve, A.J.; Eid, S.R.; Mosbacher, J.; Hricik, T.R.; Earley T.J.; Hergarden, A.C.; Andersson, D.A.; Hwang, S.W.; McIntyre, P.; Jegla, T.; Bevan, S.; Patapoutian, A. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell, 2003, 112, 819-829.
7. Bessac, B.F.; Jordt, S.E. Breathtaking TRP channels TRPA1 and TRPV1 in airway chemosensation and reflex control. Physiology (Bethesda), 2008, 23, 360-370.
8. Anand, U.; Otto, W.R.; Facer, P.; Zebda, N.; Selmer, I.; Gunthorpe, M.J.; Chessell, I.P.; Sinisi, M.; Birch, R.; Anand, P. TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons. Neurosci. Lett., 2008, 438, 221-227.
9. Bessac, B.F.; Sivula, M.; von Hehn, C.A.; Escalera J.; Cohn, L.; Jordt, S.E. TRPA1 is a major oxidant sensor in murine airway sensory neurons. J. Clin. Invest., 2008, 118, 1899-1910.
10. Kwan, K.Y.; Allchorne, A.J.; Vollrath, M.A.; Christensen, A.P.; Zhang, D.S.; Woolf, C.J.; Corey, D.P. TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for haircell transduction. Neuron, 2006, 50(2), 277-289.
11. Corey, D.P.; García-Añoveros, J.; Holt, J.R.; Kwan, K.Y.; Lin, S.Y.; Vollrath, M.A.; Amalfitano, A.; Cheung, E.L.; Derfler, B.H.; Duggan, A.; Géléoc, G.S.; Gray, P.A.; Hoffman, M.P.; Rehm, H.L.; Tamasauskas, D.; Zhang, D.S. TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells. Nature, 2004, 432(7018), 723-730.
12. Bautista, D.M.; Jordt, S.E.; Nikai, T.; Tsuruda, P.R.; Read, A.J.; Poblete, J.; Yamoah, E.N.; Basbaum A.I.; Julius, D. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell, 2006, 124, 1269-1282.
13. Bautista, D.M.; Siemens, J.; Glazer, J.M.; Tsuruda, P.R.; Basbaum, A.I.; Stucky, C.L.; Jordt, S.E. Julius, D. The menthol receptor TRPM8 is the principal detector of environmental cold. Nature, 2007, 448, 204-208.
14. Karashima, Y.; Talavera, K.; Everaerts, W.; Janssens, A.; Kwan, K.Y.; Vennekens R.; Nilius B.; Voets T. TRPA1 acts as a cold sensor in vitro and in vivo. Proc. Natl. Acad. Sci. USA, 2009, 106, 1273-1278.
15. Nassenstein, C.; Kwong, K.; Taylor-Clark, T.; Kollarik, M.; Macglashan, D.M.; Braun, A.; Undem, B.J. Expression and function of the ion channel TRPA1 in vagal afferent nerves innervating mouse lungs. J. Physiol., 2008, 586, 1595-604.
16. Jordt, S.E.; Bautista, D.M.; Chuang, H.H.; McKemy, D.D.; Zygmunt, P.M.; Hogestatt, E.D.; Meng, I.D. Julius, D. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature, 2004, 427, 260-265.
17. Bandell, M.; Story, G.M.; Hwang, S.W.; Viswanath, V.; Eid, S.R.; Petrus, M.J.; Earley, T.J.; Patapoutian, A. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron, 2004, 41(6), 849-857.
18. McNamara, C.R.; Mandel-Brehm, J.; Bautista, D.M.; Siemens, J.; Deranian, K.L.; Zhao, M.; Hayward, N.J.; Chong, J.A.; Julius, D.; Moran, M.M.; Fanger, C.M. TRPA1 mediates formalin-induced pain. Proc. Natl. Acad. Sci. USA, 2007, 104, 13525-13530.
19. Trevisani, M.; Siemens, J.; Materazzi, S.; Bautista D.M.; Nassini, R.; Campi, B.; Imamachi, N.; Andrè, E.; Patacchini, R.; Cottrell, G.S.; Gatti, R.; Basbaum A.I.; Bunnett, N.W.; Julius, D.; Geppetti, P. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc. Natl. Acad. Sci. USA, 2007, 104, 13519-13524.
20. Taylor-Clark, T.E.; Undem, B.J.; Macglashan, D.W. Jr; Ghatta, S.; Carr, M.J.; McAlexander, M.A. Prostaglandin-induced activation of nociceptive neurons via direct interaction with transient receptor potential A1 (TRPA1). Mol. Pharmacol., 2008, 73, 274-281.
21. Shakeri, M.S.; Dick, F.D.; Ayres, J.G. Which agents cause reactive airways dysfunction syndrome (RADS)? A systematic review. Occup. Med. Oxf., 2008, 58, 205-211.
22. Maestrelli, P.; Boschetto, P.; Fabbri, L.M.; Mapp, C.E. Mechanisms of occupational asthma. J. Allergy Clin. Immunol., 2009, 123, 531-542.
23. Geppetti, P.; Materazzi, S.; Nicoletti, P. The transient receptor potential vanilloid 1, role in airway inflammation and disease. Eur. J. Pharmacol., 2006, 533, 207-214.
24. Riedl, M.A.; Nel, A.E. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr. Opin. Allergy Clin. Immunol., 2008, 8, 49-56.
25. Winterbourn, C.C.; Kettle, A.J. Biomarkers of myeloperoxidasederived hypochlorous acid. Free Radic. Biol. Med., 2000, 29, 403-409.
26. MacNee, W. Pathogenesis of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc., 2005, 2, 258-266.
27. Ricciardolo, F.L.; Di Stefano, A.; Sabatini, F.; Folkerts, G. Reactive nitrogen species in the respiratory tract. Eur. J. Pharmacol., 2006, 533, 240-252.
28. Jain, K.; Siddam, A.; Marathi, A.; Roy, U.; Falck, J.R.; Balazy, M. The mechanism of oleic acid nitration by *NO(2). Free Radic. Biol. Med., 2008, 45, 269-283.
29. Trostchansky, A.; Rubbo, H. Nitrated fatty acids, mechanisms of formation, chemical characterization, and biological properties. Free Radic. Biol. Med., 2008, 44, 1887-1896.
30. Andersson, D.A.; Gentry, C.; Moss, S. Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress. J. Neurosci., 2008, 28, 2485-2494.
31. Sawada, Y.; Hosokawa, H.; Matsumura, K.; Kobayashi, S. Activation of transient receptor potential ankyrin 1 by hydrogen peroxide. Eur. J. Neurosci., 2008, 27, 1131-1142.
32. Hasegawa, T.; Malle, E.; Farhood, A.; Jaeschke, H. Generation of hypochlorite-modified proteins by neutrophils during ischemiareperfusion injury in rat liver, attenuation by ischemic preconditioning. Am. J. Physiol. Gastrointest. Liver Physiol., 2005, 289, G760-767.
33. Rahman, I. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease, antioxidant therapeutic targets. Curr. Drug Targets Inflamm. Allergy, 2002, 1, 291-315.
34. Aldini, G.; Dalle-Donne, I.; Colombo, R.; Maffei Facino, R.; Milzani, A.; Carini, M. Lipoxidation-derived reactive carbonyl species as potential drug targets in preventing protein carbonylation and related cellular dysfunction. Chem. Med. Chem., 2006, 1, 1045-1058.
35. Esterbauer, H.; Schaur, R.J.; Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med., 1991, 11, 81-128.
36. Uchida, K.; Szweda, L.I.; Chae H.Z.; Stadtman, E.R. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc. Natl. Acad. Sci. USA, 1993, 90(18), 8742-8746.
37. Andre, E.; Campi, B; Materazzi, S; Trevisani, M; Amadesi, S; Massi, D; Creminon, C; Vaksman, N; Nassini, R; Civelli, M.; Baraldi, P.G.; Poole, D.P.; Bunnett, N.W.; Geppetti, P.; Patacchini, R. Cigarette smoke-induced neurogenic inflammation is mediated by alpha,beta-unsaturated aldehydes and the TRPA1 receptor in rodents. J. Clin. Invest., 2008, 118, 2574-2582.
38. Taylor-Clark, T.E.; Ghatta, S.; Bettner, W.; Undem, B.J. Nitrooleic acid, an endogenous product of nitrative stress, activates nociceptive sensory nerves via the direct activation of TRPA1. Mol. Pharmacol., 2009, 75, 820-829
39. Hinman, A.; Chuang, H.H.; Bautista, D.M.; Julius, D. TRP channel activation by reversible covalent modification. Proc. Natl. Acad. Sci. USA, 2006, 103, 19564-19568.
40. Macpherson, L.J.; Dubin, A.E.; Evans, M.J.; Marr, F.; Schultz, P.G.; Cravatt, B.F.; Patapoutian A. Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature, 2007, 445, 541-545.
41. Bang, S.; Kim, K.Y.; Yoo, S.; Kim, Y.G. Hwang, S.W. Transient receptor potential A1 mediates acetaldehyde-evoked pain sensation. Eur. J. Neurosci., 2007, 26, 2516-2523.
42. Straus, D.S.; Glass, C.K. Cyclopentenone prostaglandins, new insights on biological activities and cellular targets. Med. Res. Rev. 2001, 21, 185-210.
43. Taylor-Clark, T.E.; Kiros, F.; Carr, M.J.; McAlexander, M.A. Transient Receptor Potential Ankyrin 1 Mediates Toluene Diisocyanate-Evoked Respiratory Irritation. Am. J. Respir. Cell. Mol. Biol., 2009, 40, 756-762.
44. Materazzi, S.; Nassini, R.; Andrè, E.; Campi, B.; Amadesi, S.; Trevisani, M.; Bunnett, N.W.; Patacchini, R.; Geppetti, P. Coxdependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1. Proc. Natl. Acad. Sci. USA, 2008, 105, 12045-12050.
45. O'Sullivan, S. On the role of PGD2 metabolites as markers of mast cell activation in asthma. Acta Physiol. Scand. Suppl., 1999, 644, 1-74.
46. Matsuoka, T.; Hirata, M.; Tanaka, H.; Takahashi, Y.; Murata, T.; Kabashima, K.; Sugimoto, Y.; Kobayashi, T.; Ushikubi, F.; Aze, Y.; Eguchi, N.; Urade, Y.; Yoshida, N.; Kimura, K.; Mizoguchi, A.; Honda, Y.; Nagai, H.; Narumiya, S. Prostaglandin D2 as a mediator of allergic asthma. Science, 2000, 287, 2013-2017.
47. Morrow, J.D. The isoprostanes - unique products of arachidonate peroxidation, their role as mediators of oxidant stress. Curr. Pharm. Des., 2006, 12, 895-902.
48. Milne, G.L.; Musiek, E.S.; Morrow, J.D. The cyclopentenone (A2/J2) isoprostanes--unique, highly reactive products of arachidonate peroxidation. Antioxid. Redox. Signal, 2005, 7, 210-220.
49. Montuschi P.; Barnes P.J.; Roberts L.J. 2nd. Isoprostanes, markers and mediators of oxidative stress. FASEB J., 2004, 18, 1791-1800.
50. Chen, Y.; Morrow, J.D.; Roberts, L.J. 2nd. Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway. J. Biol. Chem., 1999, 274, 10863-10868.
51. Kikawa, Y.; Narumiya, S.; Fukushima, M.; Wakatsuka, H. Hayaishi, O. 9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma. Proc. Natl. Acad. Sci. USA, 1984, 81, 1317-1321.
52. Gilroy, D.W.; Colville-Nash, P.R.; Willis, D.; Chivers, J.; Paul-Clark, M.J.; Willoughby, D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med., 1999, 5, 698-701.
53. Thomson, N.C.; Chaudhuri, R.; Livingston, E. Asthma and cigarette smoking. Eur. Respir. J., 2004, 24, 822-833.
54. Facchinetti, F.; Amadei, F.; Geppetti, P.; Tarantini, F.; Di Serio, C.; Dragotto, A.; Gigli, P.M.; Catinella, S.; Civelli, M.; Patacchini, R. Alpha,beta-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am. J. Respir. Cell Mol. Biol., 2007, 37, 617-623.
55. Singh, S.P.; Mishra, N.C.; Rir-Sima-Ah, J.; Campen, M.; Kurup, V.; Razani-Boroujerdi S.; Sopori, M.L. Maternal exposure to secondhand cigarette smoke primes the lung for induction of phosphodiesterase-4D5 isozyme and exacerbated Th2 responses: rolipram attenuates the airway hyperreactivity and muscarinic receptor expression but not lung inflammation and atopy. J. Immunol., 2009, 183, 2115-2121.
56. Menon, P.; Rando, R.J.; Stankus, R.P.; Salvaggio, J.E.; Lehrer, S.B. Passive cigarette smoke-challenge studies, increase in bronchial hyperreactivity. J. Allergy Clin. Immunol., 1992, 89, 560-566.
57. Pietinalho, A.; Pelkonen, A.; Rytilä, P. Linkage between smoking and asthma. Allergy, 2009, 64, 1722-1727.
58. Lundberg, J.; Saria, A. Capsaicin induced desensitization of the airway mucosa to cigarette smoke, mechanical and chemical irritants. Nature, 1983, 302, 251-253.
59. Geppetti, P.; Bertrand, C.; Baker, J.; Yamawaki, I.; Piedimonte, G.; Nadel, J.A. Ruthenium red, but not capsazepine reduces plasma extravasation by cigarette smoke in rat airways. Br. J. Pharmacol., 1993, 108, 646-650.
60. Heicklen, J. The formation and inhibition of photochemical smog. Ann. N.Y. Acad. Sci., 1987, 502, 145-159.
61. Gilmour, M.I.; Jaakkola, M.S.; London, S.J.; Nel, A.E.; Rogers, C.A. How exposure to environmental tobacco smoke, outdoor air pollutants, and increased pollen burdens influences the incidence of asthma. Environ. Health Perspect., 2006, 114, 627-633.
62. Evans, R.B. Chlorine, state of the art. Lung, 2005, 183, 151-167.
63. D'Alessandro, A.; Kuschner, W.; Wong, H.; Boushey, H.A.; Blanc, P.D. Exaggerated responses to chlorine inhalation among persons with non-specific airway hyperreactivity. Chest, 1996, 109, 331-337.
64. Mapp, C.E.; Boschetto, P.; Dal Vecchio, L.; Maestrelli, P.; Fabbri, L.M. Occupational asthma due to isocyanates. Eur. Respir J., 1988, 1, 273-279.
65. Liu, Q.; Wisnewski, A.V. Recent developments in diisocyanate asthma. Ann. Allergy Asthma Immunol., 2003, 90(5 Suppl. 2), 35-41.
66. Butcher, B.T.; Salvaggio, J.E.; Weill, H.; Ziskind, M.M. Toluene diisocyanate (TDI) pulmonary disease, immunologic and inhalation challenge studies. J. Allergy Clin. Immunol., 1976, 58(1 Pt 1), 89-100.
67. Fabbri, L.M.; Boschetto, P.; Zocca, E.; Milani, G.; Pivirotto, F.; Plebani, M.; Burlina, A.; Licata, B.; Mapp, C.E. Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am. Rev. Respir. Dis., 1987, 136, 36-42.
68. Varma, D.R.; Guest, I. The Bhopal accident and methyl isocyanate toxicity. J. Toxicol. Environ. Health, 1993, 40, 513-529.
69. Mapp, C.E.; Chitano, P.; Fabbri, L.M.; Patacchini, R.; Santicioli, P.; Geppetti, P.; Maggi, C.A. Evidence that toluene diisocyanate activates the efferent function of capsaicin-sensitive primary afferents. Eur. J. Pharmacol., 1990, 180, 113-118.
70. Abe, Y.; Takeda, N.; Irifune, M.; Ogino, S.; Kalubi, B.; Imamura, I.; Fukui, H.; Wada, H.; Matsunaga, T. Effects of capsaicin desensitization on nasal Allergy-like symptoms and histamine release in the nose induced by toluene diisocyanate in guinea pigs. Acta. Otolaryngol., 1992, 112(4), 703-709.
71. Bessac, B.F.; Sivula, M.; von Hehn, C.A.; Caceres, A.I.; Escalera, J.; Jordt, S.E. Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases. FASEB J., 2009, 23, 1102-1114.
72. Bonini, S.; Lambiase, A.; Angelucci, F.; Magrini, L.; Manni, L.; Aloe, L. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc. Natl. Acad. Sci. USA, 1996, 93, 10955-10960.
73. Obata, K.; Katsura, H.; Mizushima, T.; Yamanaka, H.; Kobayashi, K.; Dai, Y.; Fukuoka, T.; Tokunaga, A.; Tominaga, M.; Noguchi, K. TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury. J. Clin. Invest., 2005, 115, 2393-2401.
74. Abraham, W.M.; Scuri, M.; Farmer, S.G. Peptide and non-peptide bradykinin receptor antagonists, role in allergic airway disease. Eur. J. Pharmacol., 2006, 533, 215-221.
75. Proud, D. The kinin system in rhinitis and asthma. Clin. Rev. Allergy Immunol., 1998, 16, 351-364
76. Premkumar, L.S.; Ahern, G.P. Induction of vanilloid receptor channel activity by protein kinase C. Nature, 2000, 408, 985-990.
77. Sugiura, T.; Tominaga, M.; Katsuya, H.; Mizumura, K. Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1. J. Neurophysiol., 2002, 88, 544-548.
78. Chuang, H.H.; Prescott, E.D.; Kong, H.; Shields, S.; Jordt, S.E; Basbaum, A.I; Chao, M.V.; Julius, D. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature, 2001, 411, 957-962.
79. Shin, J.; Cho, H.; Hwang, S.W.; Jung, J.; Shin, C.Y.; Lee, S.Y.; Kim, S.H.; Lee, M.G.; Choi, Y.H; Kim, J.; Haber, N.A.; Reichling, D.B.; Khasar, S.; Levine, J.D.; Oh, U. Bradykinin-12- lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc. Natl. Acad. Sci. USA, 2002, 99, 10150-10155.
80. Kollarik, M.; Undem, B.J. Activation of bronchopulmonary vagal afferent nerves with bradykinin, acid and vanilloid receptor agonists in wild-type and TRPV1-/- mice. J. Physiol., 2004, 555(Pt 1), 115-123.
81. Ossovskaya, V.S.; Bunnett, N.W. Protease-activated receptors: contribution to physiology and disease. Physiol. Rev., 2004, 84, 579-621.
82. Schmidlin, F.; Amadesi, S.; Dabbagh, K; Lewis, DE; Knott, P; Bunnett, N.W.; Gater, P.R.; Geppetti, P.; Bertrand, C.; Stevens, M.E. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J. Immunol., 2000, 69, 5315-5321.
83. Su, X.; Camerer, E.; Hamilton, J.R.; Coughlin, S.R.; Matthay, M.A. Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms. J. Immunol., 2005, 175, 2598-2605.
84. Amadesi, S.; Nie, J.; Vergnolle, N.; Cottrell G.S.; Grady, E.F.; Trevisani, M.; Manni, C.; Geppetti, P.; McRoberts, J.A.; Ennes, H.; Davis, J.B.; Mayer, E.A.; Bunnett, N.W. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J. Neurosci., 2004, 24, 4300-4312.
85. Dai, Y.; Wang, S.; Tominaga, M.; Yamamoto, S.; Fukuoka, T.; Higashi, T.; Kobayashi, K.; Obata, K.; Yamanaka, H.; Noguchi, K. Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain. J. Clin. Invest., 2007, 117, 1979-1987.
86. Wang, S.; Dai, Y.; Fukuoka, T.; Yamanaka, H.; Kobayashi, K.; Obata, K.; Cui, X.; Tominaga, M.; Noguchi, K. Phospholipase C and protein kinase A mediate bradykinin sensitization of TRPA1, a molecular mechanism of inflammatory pain. Brain, 2008, 131, 1241-1251
87. Materazzi, S.; Nassini, R.; Gatti, R.; Trevisani, M. Geppetti, P. Cough sensors. II. Transient receptor potential membrane receptors on cough sensors. Handb. Exp. Pharmacol., 2009, 18, 49-61.
88. Andre, E.; Gatti, R.; Trevisani, M.; Preti, D.; Baraldi, P.G.; Patacchini, R. Geppetti, P. TRPA1 is a novel target for protussive agents. Br. J. Pharmacol., 2009, 158, 1621-1628.
89. Xu, H.; Blair, N.T.; Clapham, D.E. Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. J. Neurosci., 2005, 25, 8924-8937.
90. Bevan, S.; Hothi, S.; Hughes, G.; James, I.F.; Rang, H.P.; Shah, K.; Walpole, C.S.; Yeats, J.C. Capsazepine, a competitive antagonist of the sensory neurone excitant capsaicin. Br. J. Pharmacol., 1992, 107, 544-552.
91. Birrell, M.A.; Belvisi, M.G.; Grace, M.; Sadofsky, L.; Faruqi, S.; Hele, D.J.; Maher, S.A.; Freund-Michel, V.; Morice, A.H. TRPA1 Agonists Evoke Coughing in Guinea-pig and Human Volunteers. Am. J. Respir. Crit. Care Med., 2009, 180, 1042-1047.
92. Pavord, I.D. Cough and asthma. Pulm. Pharmacol. Ther., 2004, 17, 399-402.
93. Prezant, D.J.; Levin, S.; Kelly, K.J.; Aldrich, T.K. Upper and lower respiratory diseases after occupational and environmental disasters. Mt. Sinai J. Med., 2008, 75, 89-100.
94. Malo, J.L.; L'archevêque, J; Castellanos, L; Lavoie, K; Ghezzo, H.; Maghni, K. Long-term outcomes of acute irritant-induced asthma. Am. J. Respir. Crit. Care Med., 2009, 179, 923-928.
95. Caceres, A.I.; Brackmann, M.; Elia, M.D.; Bessac, B.F.; del Camino, D.; D'Amours, M.; Witek, J.S.; Fanger, C.M.; Chong, J.A.; Hayward, N.J.; Homer, R.J.; Cohn, L.; Huang, X.; Moran, M.M.; Jordt, S.E. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc. Natl. Acad. Sci. USA, 2009, 106, 9099-9104.
96. Holt, P.G.; Sly, P.D.; Martinez, F.D.; Weiss, S.T.; Björkstén, B.; von Mutius, E.; Wahn, U. Drug development strategies for asthma: in search of a new paradigm. Nat. Immunol., 2004, 5, 695-698.
97. Eid, S.R.; Crown, E.D.; Moore, E.L.; Liang, H.A.; Choong, K.C.; Dima, S.; Henze, D.A.; Kane, S.A.; Urban, M.O. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity. Mol. Pain, 2008, 4, 48.
98. Viana, F; Ferrer-Montiel, A. TRPA1 modulators in preclinical development. Expert Opin. Ther. Pat., 2009, 19(12), 1787-1799.
99. Petrus, M.; Peier, A.M.; Bandell, M.; Hwang, S.W.; Huynh, T.; Olney, N.; Jegla, T.; Patapoutian, A. A role of TRPA1 in mechanical hyperalgesia is revealed by pharmacological inhibition. Mol. Pain, 2007, 3, 40.
100. Perner, R.J.; Kort, M.E.; DiDomenico, S.; Chen, J.; Vasudevan, A. TRPA1 antagonists. U.S. Patent 0264480, January 2, 2009.
101. Perner, R.J.; Kort, M.E.; DiDomenico, S.; Chen, J.; Vasudevan, A. TRPA1 antagonists. U.S. Patent 0176883, January 2, 2009.